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ABSTRACT 
PERFORMANCE DIFFERENCES BETWEEN TWO GROUPS OF COMMERCIAL 
PIGS FOLLOWING EXPERIMENTAL INFECTION WITH PRRS VIRUS 1-7-4 
ERIN LITTLE 
2019 
Porcine reproductive and respiratory syndrome virus (PRRSV) is the costliest 
swine disease in North America.  Vaccines and management alone have not been 
effective in controlling this disease.  Genetic selection for resilience may be a 
complimentary approach for controlling PRRSV.  The objective of this study was to 
estimate performance differences between two groups of pigs from the same commercial 
line following infection with PRRSV 1-7-4: 1) pigs sired by boars selected based on a 
standard index (TN-S), which emphasized feed efficiency and carcass quality; and 2) pigs 
sired by boars selected based on an experimental index (TN-E), which emphasized feed 
intake, piglet vitality, and robustness.  Potential welfare and cost concerns of the use of 
PRRSV 174 to individually infect >1400 animals led to conduction of a pilot study to 
understand morbidity and mortality of PRRSV vaccinated and unvaccinated pigs.  
Results showed a 22% mortality in unvaccinated pigs and 5% in vaccinated pigs.  Thus, 
use of PRRSV 174 would provide a robust challenge but vaccination reduces excessive 
cost and mortality.  Pigs (n≅730 per sire group) were housed in a commercial research 
wean-to-finish barn.  Experimental unit was pen, 27 pens per genetic group.  All pigs 
were vaccinated for PRRSV with PRRS MLV at weaning.  Four weeks after weaning, all 
pigs were experimentally infected with 2mL of 1-7-4 PRRSV at 3.5 logs of 
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TCID50/mL.  Average daily gain (ADG), average daily feed intake (ADFI), and carcass 
characteristics were measured.  Statistical analyses were performed using a linear mixed 
model with sire group (TN-S or TN-E) as a fixed effect.  The TN-E group had 0.06 
kg/day greater ADFI than the TN-S group from 0 to 42 dpi (P=0.01).  Feed conversion 
ratio (FCR) was 0.06 (P<0.001) and 0.12 (P=0.03) less for the TN-S group from weaning 
through finishing and for 0 to 42 dpi, respectively.  Percent lean was 0.6% (P=0.02) 
greater for the TN-S group.  Pigs sired by boars selected using the experimental index 
showed no significant difference in ADG, but had greater ADFI post-challenge, while 
pigs sired by boars selected based on the standard index had significantly lower FCR.  
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Chapter 1 
LITERATURE REVIEW 
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Introduction 
This review focuses on studies conducted during the postweaning period that assess 
genetic variation in the performance of pigs in production environments; with particular 
emphasis on their response to a challenge with porcine reproductive and respiratory 
syndrome virus (PRRSV).  One goal of applied research trials is improvement of genetic 
selection strategies in an environment that replicates commercial production.  This review 
provides context for evaluating top-cross progenies of sires selected based on either a 
standard index, emphasizing feed efficiency and carcass quality, or based on an 
experimental index, which emphasized feed intake, piglet vitality, and robustness.  
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Historic breeding goals 
The swine industry is a vertically integrated industry that mainly uses large 
breeding companies to produce seedstock.  Consistent improvement through genetic 
selection of elite lines by the breeding companies allows commercial producers an 
opportunity to increase the genetic merit of their breeding stock and thus increase 
profitability.  This nucleus breeding system improves populations and gives the swine 
industry an opportunity to increase efficiency (Culbertson et al., 2017).   
Genetic selection is a tool used across livestock industries to increase production 
efficiency and decrease costs for producers.  In the swine industry, selection programs 
have typically emphasized traits with high economic value such as growth rate and 
decreased back fat thickness (Sonesson et al., 1998).  More recently, consumer preference 
has driven the industry towards a leaner product with more emphasis on meat quality.  
These realities push breeding companies to produce efficient breeding stock with both 
greater quality and yield (Barbut et al., 2008).  These performance traits are important in 
most swine production systems but in regions with high pig populations.  
In the last 20 years, the goals of selection in the swine industry have emphasized 
increased leanness, feed efficiency, and growth rate (Barbut et al., 2008).  The focus on 
feed efficiency is due to the fact that producers spend between 60 and 70% of their total 
cost of production on feed.  Feed conversion ratio (FCR), a measure of feed efficiency, is 
the ratio of feed consumed per kg gained.  Feed efficiency is strongly associated with 
feed costs and is a major influence on financial returns.  Feed intake and weight gained 
are the two traits that compose FCR.  To select for a superior FCR, a negative feed intake 
and positive weight gain are necessary for genetic gain.  Thus, feed intake and weight 
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gain are clearly economically important traits (Patience et al., 2004).  Another 
measurement of feed efficiency is residual feed intake (RFI), defined as the difference 
between observed feed intake and expected feed intake that is required for growth and 
maintenance.  This approach incorporates body composition by using growth and 
maintenance requirements (Koch et al., 1963).  Cai et al. (2008) found that after four 
generations of selection, RFI was a heritable trait (0.29) and pigs selected for low RFI 
had 1.36% greater feed efficiency (P=0.09) than unselected pigs.  The work of Cai et al. 
(2008) demonstrated the efficacy of selection for feed efficiency.  
The swine industry also uses genetic selection to improve growth rate.  Two 
studies conducted by Pipestone Applied Research (unpublished data) in 2400 head 
commercial finishing barns compared growth performance of pigs sired by boars from 
two genetic lines: 1) a line selected for increased feed efficiency and 2) a line selected for 
reduced days on feed and leaner carcasses.  Boars from each line were bred to females 
from a single dam line.  Each genetic line was a commercially available sire line 
produced by a commercial breeding company.  At marketing, pigs from line 2 were 1.0 
kg heavier (P<0.05) and harvested after 3.6 fewer days on feed (P<0.05) than pigs sired 
by boars from line 1.  Average daily gain (ADG) was 0.03 (live) and 0.02 (carcass) kg/d 
greater for pigs that had been sired by boars from line 2 on a live and carcass-basis, 
respectively (P<0.05).  However, pigs that were sired by boars from line 1 had 1.8% 
greater feed conversion ratio.  Pigs that were sired by boars from line 1 had a 0.25% 
greater average yield or dressing percentage while those sired by boars from line 2 had a 
0.9% greater percentage lean and 2.2 mm greater loin depth (P<0.05).  From this trial, it 
could be concluded that a commercial producer’s preference for a line would depend on 
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the premiums offered by the producers harvest location, space or yardage cost, feed cost 
and if they are able to capture a premium on a leaner carcass.  Line 1 would best fit a 
producer with a high feed cost, where line 2 would best fit a producer that needs a fast 
growing pig due to space limitations.  Regardless, an understanding of regional 
limitations will help producers decide on the genetics that best fit their environment. 
The second study was conducted six months after the completion of trial one.  
Trial two was conducted in the same facility, but the pigs were farrowed at a different 
sow farm.  As in the first study, the same maternal line was used for both genetic groups.  
Boars used in the second study were from two commercially available genetic lines bred 
by two different companies.  Line 1 was selected for feed efficiency and line 2 was 
selected for days on feed and carcass traits.  The results of this study were similar to the 
previous study except: line 2 had a 4% more pigs receiving an optimum price at harvest 
and days on feed were similar for both lines.  Line 1’s feed conversion advantage was 
also repeatable on a live-basis but not when calculated on the basis of carcass weights.  
Mortality rates were approximately 3%; although acute disease affected some pigs, no 
major disease outbreaks caused severe mortality or morbidity (Holtkamp et al., 2013).  
Both of these studies were conducted in a facility that represented a high health, 
commercial US pig barn.  Neither study had a known disease challenge.  
In the previous two studies, maternal lines were the same when comparing 
different genetic groups.  However, results by Johnson et al. (2002) suggest that maternal 
genetic effects can affect performance traits.  Over an eight year period, maternal genetic 
effects of four breeds on post weaning performance traits were evaluated.  Performance 
data was collected on purebred pigs in a commercial swine operation.  Maternal breed 
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genetic effects were identified for 100 d weight, postweaning ADG, average daily feed 
intake (ADFI), loin eye area (LEA) and back fat depth (BF) for the pigs born to Landrace 
females.  Pigs born to Yorkshire females also showed maternal breed genetic effects for 
100 d weights, wean – finish ADG, LEA and BF (P < .05).  Currently, most 
commercially available maternal lines are composed largely of Yorkshire and Landrace.  
This study shows variation in performance by maternal genetic group.  From these 
results, one can conclude the importance of controlling for maternal genetic effects when 
assessing performance of piglets from multiple litters. 
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Genetic mitigation of disease challenges  
Breeding goals for the swine industry emphasize economically important 
production traits like a lean and efficient carcass.  Studies have been completed showing 
success of genetic selection on performance traits in the swine industry (Cai et al., 2008; 
Pipestone Applied Research, unpublished data).  Still, the environment of a pig barn is 
rarely unaffected by various pathogens.  More recently, researchers have been working to 
include phenotypes for resilience to increase overall genetic improvement of the swine 
industry (Merks et al., 2012). 
Resilience while infected with a disease-causing pathogen may be crucial to 
agricultural systems.  Resilience is generally defined as an individual’s ability to cope 
with unpredictable perturbations.  Globally, swine producers deal with increased cost 
arising from affliction with porcine reproductive and respiratory syndrome virus 
(PRRSV) (Neumann et al., 2005).  The PRRSV greatly increases the rate of reproductive 
distress and respiratory illness in growing pigs.       
The porcine reproductive and respiratory syndrome (PRRS) Host Genetics 
Consortium (PHGC) coordinates projects to explore the host genome following infection 
with PRRSV.  The PHGC has investigated both the genotypes and phenotypes involved 
with the host response to PRRSV and estimated the heritability of those phenotypic traits 
that predict response to PRRSV infection (Hess, 2016; Boddicker et al., 2012; Boddicker 
et al., 2014).  In fact, Hess (2016) estimated heritability when infected with NVSL, a 
virulent strain of PRRSV, results were moderately high for both viral load (VL) and 
weight gain (WG) (0.31 ± 0.06 and 0.33 ± 0.06), respectively.  Additionally, the PHGC 
has developed experimental infection models that allow verification of phenotypes and 
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genotypes that predict PRRSV resilience (Lunney et al., 2011, Boddicker et al., 2012).  
Research has shown that host response differs following infection with PRRSV in diverse 
genetic groups of pigs (Dunkelberger et al., 2015; Petry et al., 2005; Vincent et al., 2005).  
Studies have been done to investigate resilience of swine to PRRSV (Greiner et al., 2000, 
Dunkelberger et al., 2015; Hess, 2016).  Resilience is defined here as a pig’s successful 
ability to maintain performance following exposure to a pathogen and is a function of 
tolerance and resistance.  Tolerance is defined as a pig’s ability to maintain performance 
given a specific pathogen load (Bishop et al., 2012).  A pig’s resistance is their ability to 
limit or completely prevent infection by the pathogen.  A resilient animal can be tolerant, 
resistant or both when exposed to a pathogen.  Many studies suggest both tolerance and 
resistance to PRRSV are moderately heritable (0.31 ± 0.06 and 0.33 ± 0.06) for WG and 
VL, respectively (Dunkelberger et al., 2015; Greiner et al., 2000; Hess, 2016, Petry et al., 
2005). 
Cost of PRRSV 
Porcine respiratory and reproductive syndrome virus has caused a significant 
negative impact on the swine industry.  It is considered the most economically 
devastating disease in the US swine industry and globally, it is considered one of the 
most economically important diseases to swine herds (Neumann et al., 2005).  Each year 
PRRS costs US producers more than 77 million dollars, which include diagnostics, 
immunizations and treatments.  Other outbreak related costs, such as implementing 
biosecurity efforts, may cost US producers up to 191 million dollars annually.  In 2013, it 
was estimated that in total the PRRSV cost producers more than three dollars per head 
marketed (Holtkamp et al., 2013).  This estimate includes preventative, costly measures 
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taken by producers to potentially reduce the disease or handle an outbreak (Holtkamp et 
al., 2013). 
History of PRRS 
In North America, PRRSV was first detected in the late 1980s (Lewis et al., 2007; 
Hill 1990).  The disease resulting from infection with PRRSV was originally named 
“mystery swine disease” until 1991 when researchers in the Netherlands were the first to 
find the causative agent was a small, enveloped RNA virus (Wensvoort et al., 1992).  At 
approximately the same time that the virus was discovered in North America, a virus 
causing pigs to show similar symptoms was discovered in Europe.  The European strain 
of PRRSV (type 1) is genetically different from the North American strain (type 2).  
Originally, clinical signs displayed by infected pigs appeared similar and the two strains 
of virus shared approximately 60% of their nucleotide sequence (Kim et al., 2010).  
Veterinarians first noticed an increase in reproductive losses of late-term sows, and if 
born alive, piglets were weak and lethargic.  In the growing phase, pigs were lethargic 
and had severe pneumonia, resulting in increased mortality and morbidity (Lunney et al., 
2010).  Prior to 2011, limited studies were completed comparing viral load and clinical 
signs between infections of PRRSV type 1 and type 2.  Martinez-Lobo and colleagues 
(2011) experimentally infected six groups of pigs with PRRSV: three groups were 
infected with different isolates of type 1 and three groups were infected with different 
isolates of type 2.  Using a mean area under the curve to quantify clinical scores weekly 
from 0-21 dpi, pigs infected by type 2 PRRSV presented with significantly longer and 
more severe clinical respiratory symptoms.  No differences were observed between pigs 
infected with type 1 and 2 PRRSV for all other symptoms of disease, viral load and viral 
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distribution after infection.  Thus, type 2 PRRSV caused increased severity of respiratory 
illness in pigs relative to the type 1 virus, which was independent of viral load or 
distribution. 
Etiology of PRRS 
The PRRSV is a small, single-stranded, enveloped, positive-sense RNA virus and 
belongs to the family Arteriviridae (Benfield et al., 1992).  Its replication rate is fast and 
error-prone, leading to a high neutral mutation rate and a higher recombination rate with 
other strains of PRRSV (Brar et al., 2014).  This high mutation rate provides the PRRSV 
with an evolutionary advantage allowing it to adapt quickly to changing environmental 
conditions.  The virus increases rate of replication in cells of the blood monocyte and 
porcine alveolar macrophage (PAM) lineage by evading viral recognition mechanisms 
(Duan et al., 1997).  These cells are actively involved in the innate immune response of 
the host (Lopez-Fuertes et al., 2000).  It does so by altering activation of innate immune 
cells which decreases immune surveillance.  Thus, PRRSV decreases the immune 
response of the lung.  When the virus inhibits the innate activity of pulmonary 
macrophages, the host becomes susceptible to secondary pathogens (Gomez-Laguna et 
al., 2013).   
PRRSV Isolate 174 
PRRSV 174 is an isolate with restricted fragment length polymorphism pattern 
that emerged in the United States in 2014.  It had evolved from the 184 family of 
PRRSV.  At least 14 infections with PRRSV 174 have occurred in breeding herds that 
were previously vaccinated against the PRRSV (Geelen et al., 2018).  The virulence of 
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the isolate played a major role in levels and length of viremia, humoral response, weight 
gain and mortality rates (Johnson et al., 2004).  Pigs infected with non-PRRSV 174 
isolates average 3-5% mortality, which may extend to approximately 30% in extreme 
cases (Nathues et al., 2017).  In contrast, infection with PRRSV 174 has been associated 
with greater rates of mortality in finishing pigs; up to 50% mortality and morbidity has 
been observed (Perez et al., 2015).  The PRRSV 174 isolate is a highly pathogenic, 
virulent strain of the virus that is prevalent in the US swine industry (Dee et al., 2018),   
Clinical Disease 
The PRRSV virus can infect pigs of all ages and production types.  In breeding 
herds, PRRS may cause reproductive failures including late-term abortions, stillborn and 
mummified fetuses.  Although the PRRSV causes reproductive failure its etiology not 
well understood.  However, it is known that the virus causes the most severe reproductive 
failures when sows are infected in the final trimester of pregnancy (Zimmerman et al., 
2006).  In growing pigs, symptoms of PRRSV infection typically include decreased 
performance and an increase in the number of pigs that are afflicted with respiratory 
diseases such as pneumonia.  Risk of secondary infections dramatically increases after 
infection with PRRSV, thus increasing the mortality rate (Rowland et al., 2012).  The 
virus can persist in tissue for long periods of time.  Zimmerman et al. (1992) was the first 
to show persistence of infection, by demonstrating transmission of PRRSV from an 
infected sow to her naïve piglets 99 dpi.  The virus has still been found in experimentally 
infected weanling pigs up to 150 dpi (Allende et al., 2000). 
Management of Disease 
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The cost of PRRS pushes veterinarians and producers to find more effective 
management tools.  Vaccines to immunize pigs against PRRSV are commercially 
available for producers.  However, the effectiveness of the vaccine depends on the 
similarity of the strain of PRRSV that is present in the production environment and the 
strain of PRRSV used to produce the vaccine.  As stated earlier, genetic diversity of the 
PRRSV is high, and thus the virus that is present in the production environment is likely 
to be genetically different from that used in producing the vaccine (Kim et al., 2011).  If 
the disease and vaccine strains are genetically homologous, vaccine protection can be 
effective.  Unfortunately, Lager et al. (1999) has shown up to 20% genomic difference in 
strains of the same type.  This variability within the PRRSV genome is thought to explain 
the inefficiencies of vaccines to cross-protect against all strains (Lunney et al., 2010).  
Antigenic and biological differences in isolates of the PRRSV have been reported (Meng, 
2000).  Differences in virulence have been observed among various isolates (Wensvoort 
et al., 1992).  These studies show the difficulties of creating a targeted efficacious 
vaccine.   
Nonetheless, PRRSV vaccines have been available to producers for over 25 years 
and are widely used to help combat the disease.  A modified live vaccine (MLV) is the 
most common commercially used vaccine type.  The MLV vaccines have protected 
against clinical diseases when animals are infected with a homologous strain (Geldhof et 
al., 2012).  Still, safety concerns exist when using a modified live or live vaccine, 
including risk of reversion to virulence (Kimman et al., 2009).  
Biosecurity is defined as the proactive protection of an animal herd from the 
introduction of any infectious agents.  Biosecurity is a major tool used to prevent disease 
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and control the large amount of potential contaminants.  Pathogen entry into a barn can 
occur through many different routes.  One route is through genetic material that is 
regularly introduced into sow farms in the form of semen or replacement females (Amass 
and Clark, 1999).  Additionally, contamination of feed and feed ingredients may be a 
vector of disease transmission (Dee et al., 2016).  Employees, visitors, birds and rodents 
are additional vectors of disease transmission (Pitken et al., 2009).  Following adequate 
down-time, or a minimum time spent away from pigs with an unknown health status prior 
to entry into other pig barns, shower and disinfectant protocols are crucial for biosecurity 
to be effective.  Although biosecurity is important for preventing PRRSV introductions, it 
is not 100% effective (Toman et al., 2017).  Elimination of PRRSV virus on a farm is 
possible and many elimination techniques are practiced.  Herd closure is a technique that 
exposes the herd to either live virus or modified-live vaccine virus and closes the herd, 
where no new gilts are introduced.  This method reduces virus spread over time because 
no new naïve animals are introduced.  Once the farm stabilizes, naïve gilt introduction is 
possible (Gillespie and Carroll, 2003).  Test and removal is another elimination technique 
that includes blood testing the entire herd and removing any positive animals.  Dee et al. 
(2001) demonstrated this method to be successful for five chronically infected breeding 
herds of <1500 animals per herd.  Dee (2004) successfully repeated this elimination 
methodology on 30 farms with larger populations and showed it to be efficacious.  Still, 
this method has limitations: the labor required for removal of positive animals and cost of 
diagnostics.  Unlike an effective biosecurity protocol, any elimination method does not 
prevent future infections.   
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Host Genetic Response to PRRSV 
Many studies have identified genetic variation among pigs in host response 
following a PRRSV infection (Halbur et al., 2011; Lewis et al., 2007; Lewis et al., 2009, 
Lewis et al., 2009).  Lewis et al., (2009) estimated genetic variation of the host response 
to tolerance of the PRRSV before and after a PRRS outbreak in commercial sows.  The 
results showed within-breed genetic variation of commercially relevant traits after PRRS 
infection.  Halbur et al., (2011) showed more severe lung scores in Hampshire pigs then 
Duroc or Meishan pigs following a PRRSV inoculation.  Lewis et al. (2009) saw a 
similar result, where the pigs with Meishan genetics were more adversely affected by 
PRRSV than the European breeds studied.   
Petry (2005) studied 400 non-vaccinated pigs, one-half of which were a Large 
White-Landrace line, selected for litter size over 20 generations, and one-half were a 
Hampshire-Duroc line, selected for lean growth and received from a commercial facility.  
Within each line, one-half of the pigs were challenged with PRRSV isolate 97-7985, the 
other half of each line was considered the control.  Body temperature via rectal probe, 
blood collection to analyze viral load levels, and body weights were collected at 
inoculation (d 0), d 4, d 7, and d 14.  All animals were euthanized and necropsied on d 
14.  Results showed a significant line effect post-inoculation and a significant interaction 
effect between line and treatment (challenged vs control) and day.  This study provided 
early evidence of genetic variation in the mechanisms that induce immune response to the 
PRRSV.   
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Selection for Disease Resilience 
Resilience to disease is the host’s ability to maintain performance following 
exposure to a pathogen.  A host with high resilience is able to limit the negative impacts 
that pathogens may have on the host and its performance.  Unlike host resistance, which 
refers directly to the host’s ability to prevent or limit infection, tolerance includes all 
immune mechanisms that are unrelated to the reduction of the pathogen.  Tolerance refers 
to the slope of performance on pathogen load.  Therefore, to quantify resistance or 
tolerance, pathogen load must be quantified.  If pathogen load, resistance and tolerance 
are determined, a higher selection accuracy and more nuanced selection decisions may be 
possible (Bishop et al., 2012).  Still, limitations like cost, labor, and data collection 
accuracy may indicate resilience is a much more practical as a selection criterion (Mulder 
& Rashidi, 2017).  Following infection, a resilient animal can be tolerant, resistant or a 
combination of the two (Lough et al., 2016).   
More recently, work has shown that genetic selection for resilience to PRRSV 
strains is possible (Rowland et al., 2012; Boddicker et al., 2014).  Dunkelberger et al. 
(2015) measured growth and viral load of pigs following PRRSV infection in two groups 
of pigs selected for high (n=99) or low (n=97) residual feed intake (RFI).  A lower 
residual feed intake represents a more feed efficient animal, whereas an animal selected 
for a higher residual feed intake has a greater actual feed intake then expected thus is less 
efficient.  No growth differences in response to a PRRSV challenge were observed 
between animals selected for high and low residual feed intake, a 0.03 kg/d difference in 
ADG was detected (P=0.10).  The more efficient (low RFI) group tended to have a lower 
viral load (P=0.09) and survival following PRRSV infection (P=0.06).  These results 
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suggest that more efficient pigs are able to handle disease stress equally or potentially 
better than less efficient pigs.  
The first genome-wide association study (GWAS) for host response to PRRSV 
was carried out by Boddicker et al. (2012).  Data were from a previous study completed 
by the PHGC.  A highly virulent isolate was used to infect healthy pigs one week after 
they were weaned.  Weekly body weights were collected pre and post-infection to 
analyze weight gain (WG).  Blood samples were collected biweekly to measure viremia 
pre and post-infection (viral load; VL).  Both collections occurred through 42 dpi when 
all pigs were euthanized.  Heritability estimates for both viral load and weight gain were 
moderate (30%).  Supported by earlier studies (Hess, 2016; Boddicker et al., 2012; 
Boddicker et al., 2014), weight gain and viral load phenotypes were negatively 
correlated.  The phenotypic correlations between VL and WG at 21 and 42 dpi were -0.22 
± 0.04 and -0.25 ± 0.04, respectively.  The genetic correlations of these two traits at 21 
and 42 dpi were -0.54 ± 0.32 and -0.46 ± 0.35, respectively.  Boddicker et al. (2012) 
found that Sus scrofa chromosome 4 (SSC4) and Sus scrofa chromosome X explained a 
greater amount of variation in VL then any other region.  SSC4 also explained some 
variation in WG.   
Upon further analysis, one region on SSC4, a 33-SNP region, was responsible for 
a large proportion of the variation in the total genomic estimated breeding value (GEBV) 
of SSC4.  Specifically, 6 SNP within the 33-SNP region accounted for 99.3% of the 
variance of the GEBV.  One SNP, WUR1000125 (WUR), captured the greatest amount 
of genetic variation (99.4% VL, 99.3% WG42).  Boddicker et al. (2012) showed that the 
WUR SNP had the largest effect of these six SNP on PRRSV VL.  This region of the 
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genome is located near the guanylate binding protein 5 (GBP5), if fully functioning this 
protein helps in host defense, specifically, inflammasome assembly.  If the host has a 
mutation at the GBP5 region and expresses the unfavorable allele, individuals are more 
susceptible to disease (Kommadath et al., 2017).  The frequency of the favorable allele 
was 16.1% in Boddicker’ et al., (2012), and the unfavorable allele has been consistently 
more frequent across studies (Dekkers et al., 2017; Boddicker et al., 2012; Boddicker et 
al., 2014).  However, a low favorable allele frequency also suggests the selection for the 
favorable allele will be effective at increasing resiliency to PRRSV infections in 
commercial swine operations.  
Greiner et al. (2000) also assessed the quantitative relationship of viremia and 
growth following PRRSV challenge.  Pigs (n=96) were penned separately and challenged 
with a 2-mL dose of PRRSV isolate JA142.  Similarly, body weight and blood were 
collected, but additionally feed intake was measured.  All parameters were measured 
once pre-inoculation and then every 4 days until 24 dpi.  A negative phenotypic 
correlation between viremia and growth was observed.  A negative correlation was also 
observed between viremia and feed intake.  For every log increase in serum PRRSV there 
was a 0.036 kg reduction in ADFI. 
The concern over vaccine efficacy across strains has led researchers to assess host 
genetic response to genetically different isolates of PRRSV.  Hess (2016) analyzed 
previous studies to compare host response to two different isolates and estimated genetic 
parameters of each isolate with WG and VL (Hess, 2016).  This study analyzed 15 
previous trials using either isolate NVSL-97-7895 (NVSL) or KS-2006-72109 (KS06).  
Correlations of WG and VL with the frequency of WUR genotypes were consistently 
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negative for both KS06 (-0.52±0.17) and NVSL (-0.74±0.10).  This study supports 
previous research that the favorable allele is dominant and the genetic correlation of WG 
and VL are moderately negative.  When infected with NVSL, Hess (2016) found that the 
WUR SNP was associated with reduction in viral load, potentially by controlling the rate 
of virus replication.  This effect was observed in the WUR genotype’s significant effect 
on peak viremia in both isolates.  On the other hand, there was no significant association 
between WUR genotype and growth rate in pigs infected with KS06, the less virulent 
strain.  A more virulent strain of PRRSV may be needed to observe a significant 
association between the selected SNP and weight gain (Hess, 2016).   
Following a PRRS outbreak, it is rare that PRRS is the only disease in the barn.  
Many studies assess PRRS resilience in facilities that contain pigs that are free of other 
common disease and where PRRSV is the only detectable virus (Dunkelberger et al., 
2015; Greiner et al., 2000; Petry et al., 2005). The most successful example of changing 
disease resilience through selection in swine is the response to F18 E. coli infection.  E. 
coli F18 causes increased diarrhea in pigs which leads to significant mortality and 
morbidity.  If pigs do not have the F18 receptor, this strain of E. coli is unable to colonize 
the porcine gut epithelium.  Therefore, selection for pigs lacking the F18 receptor has 
proven successful for countries like Belgium that have a very high prevalence (96%) of 
F18 E.coli (Coddens et al., 2008).   
Magnusson (1998) selected pigs for high and low combined cell-mediated and 
antibody immune responses were infected with Mycoplasma hyorhinis.  The results of the 
study show selection has an effect on Mycoplasma hyorhinis susceptibility, although no 
clear advantage was shown by either group (Magnusson, 1998).  Kadowaki (2012) has 
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shown that selection for resistance to swine Mycoplasmal pneumonia over five 
generations has responded to genetic selection and demonstrated the potential of selection 
for disease resistance.   
More recently, Tibbs et al. (2018) completed a study assessing natural antibody 
(NAb) levels in healthy pigs exposed to natural challenges including PRRS disease, 
bacterial, and other viral infections.  Results of this study showed a positive phenotypic 
correlation between IgG NAb and IgM NAb for all four antigens tested (P<0.001).  IgG 
NAb and IgM NAb levels were also both moderately heritable (0.11-0.19 and 0.27-0.39, 
respectively).  These results show that genetic selection could be a useful tool to improve 
NAb levels.  A review by Guy et al. (2012) stated the need for more studies that describe 
and account for environmental factors when assessing disease resistance and tolerance.  
To always assume a constant environmental effect in pig barns is unrealistic.  The PRRS 
virus predisposes swine populations to bacterial and viral infections, with the likelihood 
of secondary infections occurring with increased virulence of the PRRS virus (Gomez-
Laguna, 2013; Hess, 2016).    
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Conclusion 
Genetic selection has been widely used in the swine industry to select for 
economically important traits such as feed efficiency and growth rate.  This is important 
for swine producers because feed is the largest cost to producers in the growing phase 
and as pigs become more efficient, the amount of feed necessary to achieve an ideal 
market weight will decrease. Improved health and robustness to disease are also 
becoming increasingly important for modern pig production. Results from previous 
studies demonstrate the potential of using genetic selection to breed pigs for increased 
resilience to PRRSV-infection. Therefore, breeding pigs for improved resilience to PRRS 
may be used as an additional tool to reduce morbidity, mortality, and economic losses 
due to PRRSV-infection.  
Results from previous studies also provide evidence of genetic variation in 
response of pigs to infection with pathogens commonly found in production settings, 
suggesting the potential of using genetic selection to breed pigs for improved general 
robustness to disease in commercial production.  Due to increased susceptibility to 
polymicrobial diseases following PRRSV-infection, there is a need for more studies 
conducted in commercial-like facilities to allow secondary diseases to develop in the 
barn.  Evaluating genetic resilience of pigs following PRRS and secondary disease will 
offer repeatable results to producers.  Researchers need to use caution when conducting 
large-scale disease challenge models with virulent diseases.  Potential concerns like 
excessive mortality and morbidity could affect the results and increase trial costs.  A 
well-designed pilot study gives confidence in the experimental design and acceptability 
of potential outcomes. 
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Introduction 
 Completion of a pilot study allows researchers to “try-out” methods or materials 
to give advanced warning on areas of potential failure in the main study (Van Teijlingen 
and Hundley, 2001).  Leon et al., (2011) stated that pilot studies are a vital step in 
understanding the experimental design and potential protocol modifications for a larger, 
main study.  When developing the protocol for chapter 3, the use of a robust isolate was 
crucial to illicit a strong disease response.  The use of a local, relevant isolate was also 
important.  PRRSV 174 is common in the Midwest and has been repeatedly shown to 
have a high degree of pathogenicity (Dee et al., 2018).  Perez et al. (2015) found upwards 
of 50% mortality following a PRRSV 174 outbreak, where previous local isolates caused 
no more than 30% mortality in finishing pigs.   
 Commercially available PRRSV vaccines have been used in the swine industry 
for over 25 years and include modified-live and killed vaccines.  Killed vaccines offer a 
stability of storage advantage.  However, at this point, no protection or prevention of the 
disease has been shown after vaccination with a killed PRRSV vaccine (Scortti et al., 
2006).  Thus, producers prefer to use a modified-live PRRSV vaccine.  PRRSV modified-
live vaccines have shown to significantly reduce viremia and clinical signs following a 
PRRSV infection (Linhares et al., 2012).  
 The use of a virulent disease in a large-scale, experimental infection model could 
potentially cause an excessive mortality rate.  Therefore, prior to conducting the main 
study, we estimated mortality in vaccinated and non-vaccinated pigs and tested whether 
PRRSV-1-7-4 is a suitable, and not excessive, isolate to experimentally infect 100% of 
the population.  Therefore, the objectives of the pilot study were to answer two questions.   
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1) What are the clinical effects of PRRSV 174 challenge? 
2) What is the effect of PRRSV vaccination on these outcomes? 
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Materials and Methods 
Welfare Statement 
Prior to the start of this study, Pipestone Applied Research (PAR) institutional 
animal care and use committees (PAR IACUC 1-18) reviewed and approved the trial 
protocol, mortality standards and caretaker handling certification.  Throughout the trial 
these guidelines were upheld.  A visual assessment of all pigs and the environment in 
which they lived, including verification of food and water source, was completed daily by 
a caretaker under the direction of the site veterinarian.  The caretaker conducted the daily 
assessment using the individual pig care (IPC) scoring system (Pineiro et al., 2014) that 
classifies animal health status.  The system classifies “A” as acute sickness, “B” as sub-
acute sickness and “C” as severe, chronic illness.  Pigs classified as a “B” or “C” were 
given antibiotic treatment if possible.  If the approved protocol prevented antibiotic 
treatment, pigs classified as “B” or “C” were monitored more frequently.  If deemed 
immobile and unable to eat or drink, the pig was euthanized.  Pigs were humanely 
euthanized by a qualified caretaker that had been trained by the Pipestone Welfare 
Department and veterinarian.   
Animal Source, Housing and Post-Weaning Experimental Design 
Pigs (n=200) were placed into a nursery near Jackson, MN.  All pigs were 
confirmed PRRSV wild-type negative.  Just over 4 weeks prior to inoculation, pigs 
(n=100) were randomly allocated to the unvaccinated group (UnVAX) and shipped to the 
research nursery located near Edgerton, MN.  All pigs that stayed at the original nursery 
near Jackson, MN received a 2 mL PRRSV modified-live virus vaccine (Ingelvac 
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PRRSV ATP, Boehringer Ingelheim) (VAX).  On wean day, -2 days post-infection (dpi), 
the vaccinated pigs were shipped to the research facility.  Upon arrival, pigs were placed 
into pens by vaccine status.  Gender was balanced within each pen.  Therefore even-
numbered pens contained barrows and gilts of vaccinated pigs and odd-numbered pens 
contained barrows and gilts of unvaccinated pigs.  Pen weights were taken once pen 
allocation was established.   
PRRSV 174 Inoculation 
At 0 dpi, all pigs were experimentally infected with 2 x 103.5 TCID50 of PRRSV 
lineage 1 isolate 174.  Homology between the virus and vaccine strain were 87%.  
Following guidelines from Dee et al. (2018) that used the same pathogenic variant of 
PRRSV, regular visits by the attending veterinarian at Pipestone Vet clinic were 
conducted to assess when antibiotic intervention was necessary.  A “watch” list was 
created daily by the caretaker showing a list of unthrifty pigs that are sick and require 
intervention.  When the watch list reached 20% of the population, mass medication 
would be administered.  This occurred at 7 and 14 dpi.  At 7 dpi, Excede (ceftiofur 
crystalline free acid, Zoetis, Parsippany, NJ) was administered due to the respiratory 
symptoms associated with the PRRS disease.  At 14 dpi, Excede and Predef (anti-
inflammatory, Zoetis, Parsippany, NJ) were administered, again to reduce the respiratory 
symptoms associated with the PRRS disease and Predef to reduce fevers shown in the 
pigs.   
Phenotype Collection 
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At 7 and 14 dpi, all pigs were graded using the Galina robustness score (Pantoja et 
al., 2013).  This system assigns each pig a value of 1-5 based on general disease clinical 
signs shown.  A pig scored as a 1 is a normal healthy pig showing no signs of disease, a 
“2” pig shows early signs of disease, a “3” pig is showing moderate signs of disease, a 
“4” pig has advanced clinical disease signs and a “5” pig is a euthanasia candidate.  
Mortalities were recorded throughout the study.  This trial was terminated four weeks 
after challenge. 
Statistical Analysis 
 Data collected from 0 to 24 dpi were analyzed as a linear mixed model in 
R.  For the mortality and robustness score data to be analyzed at the pen level, the 
outcome and robustness scores assigned to each pig were averaged within the pen and 
represented a % mortality, average robustness score (7 dpi.), average robustness score (14 
dpi.) for each pen.  The following model was used for all traits listed above: 
𝑦 = 𝑉𝑎𝑐𝑐𝑖𝑛𝑒𝑖 + 𝑒 
In this equation, 𝑦 represents the response variable (mortality or robustness 
score), 𝑉𝑎𝑐𝑐𝑖𝑛𝑒𝑖 represents the i
th vaccine status (VAX or UnVAX).  
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Results 
The mortality rate for the vaccinated group was 5% (±0.03) while the 
unvaccinated group had a 22% (± 0.03) death rate (P<0.01).  At 7 dpi, the vaccinated 
group averaged a 2.59 (±0.13) on the robustness scale, while the unvaccinated group 
averaged a 3.13 (±0.13) on the robustness scale (P=0.01).  At 14 dpi, the vaccinated 
group averaged a 2.04 (±0.15) on the robustness scale, while the unvaccinated group 
averaged a 3.25 (±0.15) on the robustness scale (P<0.01) (Table 2.1).   
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Discussion 
 Conducting a pilot study allows researchers the opportunity to understand 
potential issues with an established protocol and the experimental design involved.  An 
experimental infection model with PRRSV 174 could potentially cause a significant 
mortality and morbidity in a large commercial finisher.  Therefore, the objectives of the 
pilot study were to understand the clinical effects PRRSV 174 challenge in vaccinated 
and unvaccinated pigs. 
 Results of this study showed the effectiveness of a modified-live PRRSV vaccine 
against an experimental infection with PRRSV 174.  Expanding the mortality rates seen 
in the pilot study to the scope of the study in Chapter 3 would be expected to result in an 
excessive mortality rate of over 320 pigs.  Additionally, the unvaccinated group had a 
greater average Galina score at both 7 and 14 dpi.  Suggesting that morbidity was also 
greater in the unvaccinated group. 
A major extrinsic effect on performance that can increase pig weight variation within a 
barn is exposure to pathogens.  Thus, no surprise that variation in the robustness score 
was greater at both 7 and 14 dpi in the UnVAX group.  This variation in morbidity 
translates to greater weight and performance variation within the UnVAX group.  
Previous work done by Patience (2004) emphasizes the importance of decreased pig size 
variation across a swine barn.  During the growing phase, dietary nutrients are less 
efficiently utilized when pig size within a pen is high (O’Quinn et al., 2001).  Increased 
variability in finishing barns decreases the on-farm efficiency.  Therefore, the pilot study 
suggested that the use of a vaccine can decrease variation across a group of pigs if faced 
with a PRRS disease outbreak.   
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Conclusion 
Based on the results, a PRRSV modified-live vaccine will be administered to all pigs four 
weeks prior to experimental infection with PRRSV 174.  We concluded that vaccination 
was necessary to keep mortality rates manageable.  Still, a 5% mortality rate in the 
vaccinated pigs suggest the use of PRRSV 174 in the pilot study provided a robust 
challenge to the pigs regardless of vaccination status.  
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 Table 2.1: Comparison of percent mortality and robustness scores 
between (VAX) vaccinated pigs and (UnVAX) unvaccinated pigs. 
(SEM) 
  Sire Group 
 
VAX UnVAX P-value 
Mortality (%) 5.0% (0.03) 22.4% (0.03) <0.01 
Average Robustness Score, 7 dpi 2.59 (0.13) 3.13 (0.13) 0.01 
Average Robustness Score, 14 dpi 2.04 (0.15) 3.25 (0.15) <0.01  
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Figure 2.1: Variation in Robustness Score at 7 and 14 dpi. 
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Chapter 3 
PERFORMANCE DIFFERENCES BETWEEN TWO GROUPS OF COMMERCIAL 
PIGS FOLLOWING EXPERIMENTAL INFECTION WITH PRRS VIRUS 1-7-4 
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Introduction 
The swine industry has long used genetic selection to increase production 
efficiency by selecting for economically important traits (Sonesson et al., 1998).  More 
recently, producers have realized the importance of resilient production animals which 
can decrease costs and increase welfare and sustainability.  Consequently, breeding 
objectives should shift to include selection for increased resilience, which is the ability to 
maintain performance following exposure to a pathogen (Greiner et al., 2000).   
Porcine reproductive and respiratory syndrome (PRRS) virus is one of the most 
economically devastating viruses to global pork producers (Neumann et al., 2005).  Due 
to the nature of the virus, a decrease in immune surveillance occurs allowing secondary 
pathogens to cause disease in affected animals (Gomez-Laguna et al., 2013).  In 2013, it 
was estimated that the disease and associated preventative measures cost producers up to 
three dollars a pig marketed (Holtkamp et al., 2013).  Other tools such as vaccination and 
biosecurity are available to the industry but neither offer full protection from the virus.  
Lack of full protection is largely due to a fast, error-prone replication rate of the PRRSV 
that allows it to mutate quickly (Brar et al., 2014).  Still, PRRSV vaccines are used by 
producers with success dependent on the genetic similarity of the strain of virus used in 
producing the vaccine and the strain of virus that is present in the production environment 
(Lager et al., 1999; Lunney et al., 2010).   
The objective of this study was to evaluate performance differences in pigs sired 
by boars that had been selected from a single population using either a standard or 
experimental selection index following experimental infection with PRRS virus 1-7-4.  
The standard index emphasized feed efficiency and carcass quality.  The experimental 
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index emphasized feed intake, piglet vitality and robustness.  Isolate 1-7-4 is a prevalent 
strain within the Midwest that is considered highly pathogenic and virulent (Dee et al., 
2018; Geelen et al., 2018; Perez et al., 2015).    
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Materials and Methods 
Welfare Statement 
Prior to the start of this study, the South Dakota State University (SDSU) and 
Pipestone Applied Research (PAR) institutional animal care and use committees (SDSU 
IACUC 18-030A and PAR IACUC 1-18) reviewed and approved the trial protocol, 
mortality standards and caretaker handling certification.  Throughout the trial these 
guidelines were upheld.  A visual assessment of all pigs and the environment in which 
they lived, including verification of food and water source, was completed daily by a 
caretaker under the direction of the site veterinarian.  The caretaker conducted the daily 
assessment using the individual pig care (IPC) scoring system (Pineiro et al., 2014) that 
classifies animal health status.  The system classifies “A” as acute sickness, “B” as sub-
acute sickness and “C” as severe, chronic illness.  Pigs classified as a “B” or “C” were 
given antibiotic treatment if possible.  If the approved protocol prevented antibiotic 
treatment, pigs classified as “B” or “C” were monitored more frequently.  If deemed 
immobile and unable to eat or drink, the pig was euthanized.  Pigs were humanely 
euthanized by a qualified caretaker that had been trained by the Pipestone Welfare 
Department and veterinarian.   
Animal source and pre-weaning protocol 
All pigs were sourced from a 5,000-head, PRRSV naïve, sow breeding farm 
located in northeastern South Dakota, USA. Topigs Norsvin parent females (Landrace x 
Large White) were mated using semen from a Topigs Norsvin synthetic sire line to 
produce the pigs used for this study. Sires used for this study were selected based on a 
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standard index (TN-S) and an experimental index (TN-E) for robustness to disease 
challenge.  To select the sires for each group, a TN-S and TN-E customized index value 
was calculated for each boar from the stud used to supply the semen for the trial. The 
eleven boars with the highest TN-S customized index values and the eleven boars with 
the highest TN-E customized index values were selected as sires for the TN-S and TN-E 
groups, respectively. Customized indices were constructed using combinations of 
selected traits derived from the Topigs Norsvin Selection Index. The TN-S index 
included traits related to feed efficiency and carcass quality. The TN-E index included 
traits related to robustness and feed intake.  When the immune system is under stress due 
to disease challenge, a decrease in feed intake leading to anorexia can occur (Li & 
Patience, 2017).  Thus, increased feed intake was predicted to improve resilience to a 
disease challenge.   
Using artificial insemination and gestation stall housing, an equal number of sows 
and gilts were randomly bred to boars from one of the two sire groups.  Unusual for the 
commercial industry, single-sire semen was used.  Therefore, if a sow or gilt showed 
signs of heat on day 2, she was bred again with the same boar number as day 1.  If 
needed, she was bred again on day 3, again with the same boar number.  Sows were 
farrowed in crates.  Once farrowing occurred, all piglets were tagged with a Caisley ear 
tag (Caisley Eartag Limited, North Yorkshire UK).  This ear tag simultaneously took a 
tissue sample from the piglet when the tag was inserted into the ear.  The ear tag 
identified sire group for each piglet.  Information including birth weight, dam ID and 
parity were recorded at birth.  Additionally, a tissue sample was taken from the ear of 
each dam.  About 1,000 pigs of each sire group were tagged.  Eleven unique boars from 
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each sire group were bred to 69 (TN-E) and 72 (TN-S) dams.  The breeding farm staff 
followed their standard operating procedures through weaning, including “fostering” of 
piglets.  Fostering piglets allowed staff to move newborn piglets, within 24 hours of birth, 
of extreme size (small or large) relative to their littermates to another dam, matching litter 
size to sow teat count and limiting competition amongst littermates.  The piglets’ 
biological and foster dams were recorded.  At approximately 21 days of age, piglets were 
weaned to the finishing site if they weighed >3.6 kg and did not show clinical illness, 
lameness or deformity.  Piglets that were unable to be weaned due to these classifications 
were humanely euthanized.  Per sow farm protocol, all pigs meeting the trial criteria were 
given .5 cc of Baytril (Bayer Healthcare LLC) prior to weaning. 
Housing and post-weaning experimental design 
The pigs weaned to a 2400 head wean-to-finish barn located in southwestern 
Minnesota, USA.  This barn is tunnel ventilated with 2 rooms consisting of 39 and 42 
pens, although only 54 pens (26 and 28 per room) were used for this study.  Each room 
contains a separate, but identical, ventilation system (Expert Series, Automated 
Production) that regulates barn environment by using a temperature curve.  Individual 
and pen wean weights were taken and a Radio Frequency Identification (RFID) tag was 
placed opposite the Caisley tag in each pig’s ear.  Weaning weights for TN-E and TN-S 
sired pigs averaged 6.15 (±0.13) and 6.20 (0±.13) kg, respectively.  Across the barn, the 
wean age ranged from 14-29 days of age and the average wean age was 20.3 (±0.3) and 
20.4 (±0.3) d for TN-E and TN-S sired piglets, respectively.  Due to the large number of 
pigs entering the research barn, the pigs were received over 5 weaning events.  Thus, 
wean weight, wean weight date and wean age varied within treatment group but was not 
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significantly different across treatment groups. On the final wean day, all pigs were 
vaccinated with a 2 mL PRRSV modified-live virus (Ingelvac PRRSV ATP, Boehringer 
Ingelheim). 
Because pigs were penned together by sire group, the experimental unit was the 
pen.  The trial utilized a randomized block design with 27 blocks.  Each block consisted 
of two pens, one containing pigs sired by boars from the TN-E line and one pen 
containing pigs sired by boars from the TN-S line.  Pens within each block were located 
immediately adjacent to each other.  Block was used to account for environmental 
variation such as humidity, temperature, air quality and other environmental factors 
across the tunnel ventilated barn.  Each pen consisted of 27 pigs, which were randomly 
selected from the wean group, except that the smallest 27 pigs of each group were placed 
into a single block, limiting competition equally for the two small pens.  This prevents 
fallout from the smallest group of piglets within their genetic group.  Male and female 
pigs were penned together with an equal sex-ratio in each pen of a block.  A 136 kg 
Crystal Spring 4-hole dry feeder was located in each pen, allowing 0.65 sq. m of floor 
space per pig and 34.93 cm head space per feeder hole.  Additionally, each pen had 2 cup 
water dishes.  Feed and water were provided ad libitum.  An automated feeding system 
was used for all pens, which tracked the time feed was delivered and the amount of feed 
delivered to each pen (Feedlogic Corporation, Willmar, MN).     
PRRSV 174 Challenge  
Four weeks post-vaccination, pigs were challenged with PRRSV lineage 1 strain 
174 injected intramuscularly (dose = 2 x 103.5 tissue culture infectious (TCID50) dose) 
under the direction of veterinarians.  Following guidelines from a previous study that 
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used the same pathogenic variant of PRRSV (Dee et al., 2018), weekly visits by both the 
attending veterinarian and the welfare director at Pipestone Vet clinic were conducted to 
assess when antibiotic intervention was necessary.  A “watch” list was created daily by 
the caretaker showing a list of “B” or “C” pigs, using the IPC scoring system.  When the 
watch list reached 20% of the population, mass medication would be administered.  This 
occurred at 21 dpi, therefore, the entire barn received an IM injection of Excede (ceftiofur 
crystalline free acid, Zoetis, Parsippany, NJ) and Predef (anti-inflammatory, Zoetis, 
Parsippany, NJ).  Excede is used to reduce the respiratory symptoms associated with the 
PRRS disease and Predef is an antinflammatory that reduces fever in pigs.  At 26 dpi, 
water-soluble LinxMed (Lincomycin Hydrochloride Powder, Bimeda, Oakbrook Terrace, 
IL) was distributed through the water to all pens for 7 days.  Lincomycin was used to 
combat pneumonia and arthritis symptoms in the pigs. 
Diagnostic Testing 
Starting the week prior to inoculation, weekly oral samples were taken via saliva 
rope collection.  These samples were sent to South Dakota State University and tested for 
PRRSV and Influenza (IAV).  If the sample came back positive for PRRSV prior to 
challenge, the virus was sequenced to confirm the vaccine strain caused the positive test 
result.  Only the vaccine strain was found in the pigs prior to PRRSV inoculation.  On a 
regular basis, mortalities were necropsied by a trained caretaker and samples were 
submitted to SDSU to monitor pathogens present throughout the study.   
Phenotype Collection 
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Average daily gain (ADG), feed conversion ratio (FCR) and average daily feed 
intake (ADFI) were recorded and calculated for each treatment group at weaning and on 
0, 13, 42, and 110 dpi.  Marketing started on 111 dpi and pigs were marketed over a 5-
week period on a fixed weight basis with a goal of 127 kg.  All pigs that were sent to the 
packing plant weighing >104 kg void of defects including umbilical hernias and intact 
males were classified as full value (FV).  Pigs weighing <104 kg or with a defect were 
sent to secondary markets and classified as light or defect cull, respectively.  Pigs that 
died after weaning were assigned to a separate category.  The FV pigs were harvested at a 
packing plant where hot carcass weight, % lean, back fat and loin depth was measured 
and recorded.  Individual weights were collected on the morning of marketing and a hot 
carcass weight was collected during harvesting which were both used to calculate a 
carcass yield.  
Statistical Analysis 
Data collected during the weaning-to-finish period and 0 – 42 dpi were analyzed 
using a linear mixed model in R.  For the final outcome (FV, light, defect, and mortality) 
and carcass data to be analyzed at the pen level, the outcomes assigned to each pig and 
carcass phenotypes were averaged within the pen and represented a % full value, % 
mortality, % defect cull, % light cull, % yield, % lean, back fat thickness, loin depth and 
hot carcass weight for each pen.  The following model was used for all traits listed above: 
𝑦 = 𝑆𝑖𝑟𝑒𝑖 + 𝐵𝑙𝑜𝑐𝑘𝑗 + 𝑒 
In this equation, 𝑦 represents the response variable (final outcome or carcass 
traits), 𝑆𝑖𝑟𝑒𝑖 represents the i
th sire group (TN-E or TN-S) and 𝐵𝑙𝑜𝑐𝑘𝑗 (n=27) represents 
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the jth random location in the barn.  Day 0 weight had a significant association with 0-42 
ADG and FCR, and thus was used as a covariate in the statistical model for 0-42 ADG 
and FCR.  
Another linear mixed model was used to estimate effect of sire group on birth 
weight and ADG from birth to weaning.  The data were analyzed using the model: 
𝑦 = 𝑆𝑖𝑟𝑒𝑖 + 𝐺𝑒𝑛𝑑𝑒𝑟𝑗 + 𝐵𝑖𝑟𝑡ℎ𝑠𝑜𝑤𝑘(𝑆𝑖𝑟𝑒) + 𝑒 
In this equation, 𝑦 represents the response variable (birth weight or birth- wean 
ADG) of the individual pigs, 𝑆𝑖𝑟𝑒𝑖 represents the i
th sire group, 𝐺𝑒𝑛𝑑𝑒𝑟𝑗 represents the j
th 
gender of the pig and the random effect of birth sow represents the dam of each piglet 
and is nested within Sire.  Effects of birth date and sire group by gender interaction were 
not statistically significant for either trait (P > 0.10) and thus were not included in the 
final model.  A p-value of ≤ 0.05 was used as the criterion for statistical significance.  
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Results 
Pre-wean outcomes 
Table 3.1 shows the birth-to-weaning performance of the two genetic groups.  The 
TN-S sired group was .07 kg heavier at birth (P = 0.06).  Birth to wean ADG was not 
statistically different between groups.  Males were 0.05 kg heavier at birth (<0.01).  At 
weaning, the weaning weights (P = 0.65) and weaning ages (P = 0.86) were not different 
between sire groups. 
Post-wean outcomes 
There were no significant differences in ADG or ADFI during the wean-to-finish 
period (P = 0.27).  During the period from weaning to harvest, the TN-S sired group had 
a 0.06 lower FCR (P < 0.01) than the TN-E sired group.  Narrowing in on the challenge 
and post-challenge period, there was still no statistically significant difference in ADG 
between the sire groups.  However, from 0 – 42 dpi, the TN-E sired pigs consumed 0.6 
kg/d more than the TN-S sired group (P < 0.01).  Again, the TN-S sired pigs had a lower 
FCR (P < 0.01) (Table 3.2). 
Carcass Attributes 
In regards to carcass attributes (Table 3.3), there were no statistically significant 
differences between sire groups for hot carcass weight, percent yield, back fat, or loin 
depth.  The TN-S-sired pigs had a significantly greater % lean (P = 0.02). 
Final outcomes 
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A greater number of mortalities were observed in the TN-E sired pigs (118 
mortalities) than the TN-S sired pigs (105 mortalities), although this difference was not 
statistically significant (Table 3.4).   
Pathogens detected 
Pathogens detected throughout the study are shown in Table 3.5.  The source farm 
was positive for influenza throughout this study.  Therefore, the piglets were positive for 
influenza when they arrived at the research barn.  Prior to challenge, most necropsied 
pigs were also positive for Streptococcus suis.  Fecal samples collected from a subset of 
pens were positive for rotavirus, but that disease was limited to only a small number of 
pens and was cleared up prior to challenge.  PRRSV 1-7-4 was detected in the pooled 
oral samples three days after challenge.  Mortalities were necropsied and were positive 
for Streptococcus suis, Actinobacillus suis, Haemophilus parasuis and Pasturella 
multocida.  In addition, at around eight weeks post-challenge, Bronchopneumonia and 
Escherichia coli haemolytic were detected in the tissue of necropsied pigs. 
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Discussion 
Selective breeding is a tool used in many livestock species to increase the rate of 
genetic improvement (Nicholas, 1997).  Feed costs amount to the greatest expense for 
swine producers, thus selection for improved feed efficiency and growth rate fit 
consumer and producer preferences (Barbut et al., 2008).  More recently, producers 
realize the benefits of increased robustness in their pig populations. For these reasons, 
breeding objectives should be modified to breed pigs for improved health and 
survivability (Merks et al., 2011).   
Globally, the PRRS virus has had a significant impact on swine producers.  Since 
recognition of the virus in the late 1980s producers have faced major economic losses due 
to PRRSV.  The severity and loss associated with the disease varies.  Following infection 
with PRRS virus, the susceptibility of the host to secondary infection increases 
(Niederwerder et al., 2015).  Due to evasion mechanisms of the virus, immune 
surveillance is less effective and polymicrobial infections are more likely to occur 
(Gomez-Laguna et al., 2013).  Therefore, the purpose of this study was to assess 
performance differences in pigs sired by boars selected based on a standard (TN-S) or 
experimental index emphasizing resilience (TN-E) in a commercial facility following 
experimental infection with PRRS virus 1-7-4. 
Performance characteristics between the TN-E and TN-S lines were not 
substantially different.  Boars were selected using two different customized selection 
indices, but originated from the same population.  Thus, only one-half generation of 
selection had occurred, which may be the main reason that minimal performance 
differences were observed between lines.  In contrast, results from previous studies show 
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that significant performance and robustness differences existed between lines that were 
divergently selected over five to twenty generations (Dunkelberger et al., 2015; Doeschl-
Wilson et al., 2009; Mpetile, 2014; Faure et al., 2013).  Thus, selection based on each 
index over additional generations may result in greater performance differences between 
pigs sired by boars from each line.  Dams of all of the pigs that were evaluated were of 
the same genetic line and multiplier to reduce the potential of sire x dam confounding 
effects.   
Still, results of this study showed a significantly better FCR for the TN-S group 
during the wean-to-finish period and 0 – 42 dpi.  Although the TN-E group had a 
significantly greater feed intake 0 – 42 dpi, ADG was similar for the two genetic groups.  
The TN-E sired boars were selected for increased feed intake, while the TN-S sired boars 
were selected for feed efficiency, so this result was not surprising.  This result suggests 
that increased feed intake does not always lead to faster growth rates.  Although not 
statistically significant, a 2% (±0.02) greater mortality rate was observed for pigs sired by 
TN-E boars.  Dunkelberger et al. (2015) showed that more feed efficient pigs may 
respond better to PRRSV infection.  Because only the TN-S index emphasized feed 
efficiency, the present results were consistent with Dunkelberger et al. (2015).  In 
addition, lean percentage was significantly superior for TN-S, the group sired by boars 
selected for feed efficiency.  Many studies have reported selection for residual feed 
intake, a measure of feed efficiency, had carcasses with significantly greater percent lean 
(Smith et al., 2011; Arthur et al., 2009; Faure et al., 2013).  
A robust animal is one which is capable of adapting to stressors while staying 
healthy and performing well (Herrero-Medrano et al., 2015).  Regardless of health status, 
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mortality is still one of the largest causes of economic loss in swine production (Maes et 
al., 2001).  Neumann et al., (2005) found that 88% of the total cost of PRRSV infections 
is attributed to decreased performance and increased mortality rates.  The rate of FV pigs 
at harvest time is one of the most important measurements of robustness.  The FV pigs 
represent a percentage of the population excluding mortalities, light and defect culls.  
These pigs were robust enough to tolerate the disease challenge and grow efficiently 
enough to be harvested above a minimum weight set by packing plants (104 kg).  No 
significant differences in FV pigs were detected between the two genetic groups.  The 
experimental group was selected for piglet vitality and robustness; potentially these 
phenotypes do not correlate with mortality.  Each genetic group contained 27 replicates; 
to achieve 80% power at a significance level of 5%, a 30% difference would need to be 
observed.  Cornelison et al. (2018) found only an 18% range in FV pigs of low and high 
natural disease challenge placed in the same environment.  Detecting a 30% difference in 
FV between two groups infected with the same disease and raised in a common 
environment is unreasonable.   
The increased rate of polymicrobial diseases following a PRRS disease outbreak 
suggests the importance of increased general disease immunity (Lunney et al., 2011).  
Therefore, conducting this study in a facility that is representative of commercial 
production is a strength of this trial.  It also allows for more direct inference to 
commercial production.  The rate of FV pigs marketed ranged from 81.8% (TN-E) to 
83.7% (TN-S) between genetic groups.  Cornelison et al. (2018) evaluated three levels of 
naturally occurring health challenges in three commercial barns having similar 
environments.  The three levels of health challenges included low, moderate and high 
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exposure to pathogens.  This resulted in 89.2%, 80.5% and 70.6% of FV pigs marketed, 
respectively.  The moderate to high health challenged groups reflect the performance of 
the pigs in this study.  
Surveillance of pathogens throughout this study represent a realistic array of diseases that 
would typically infect a pig barn affected by PRRSV.  Yu (2012) reported that highly 
pathogenic PRRS virus accelerates the rate of infection and load of Haemophilus 
parasuis.  Our results were consistent with Yu (2012); we detected, not only 
Haemophilus parasuis, but also Influenza, Actinobacillus suis, Pasturella multocida, 
Bronchopneumonia and Escherichia coli haemolytic.  Assessment of wean to finish 
performance objectives in response to an experimental PRRS virus 174 infection with 
secondary infections had yet to be studied prior to this study being completed.   
Rowland and colleagues (2012) identified that lack of control of observational 
data as a major limitation of field studies.  Because we cannot control for environmental 
variables in field studies, including pathogen exposure, a larger number of animals are 
required to achieve sufficient power to identify differences among groups.  Our study 
controlled PRRS virus exposure levels, used one maternal genetic line and balanced for 
parity, wean age and barn effect across both genetic groups.  Cho et al., (2005; 2006) 
repeatedly found greater viral load concentrations of PRRS virus in younger pigs, 
suggesting the importance of balancing age at challenge between genetic groups.  Block 
accounted for a large portion of variation in all statistical tests.  This result is to be 
expected due to the large variation in temperature, air quality, humidity, and other 
environmental factors across a tunnel ventilated barn.  The design of this study exercised 
much control over unknown variation while still assessing the pigs in a representative 
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commercial facility infected with a relevant, virulent strain and common secondary 
pathogens. 
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Conclusion 
Between the genetic groups evaluated in this study, minimal differences in 
performance were observed.  It is possible that genetic difference between the boar lines 
used in this experiment were not large enough to result in statistically significant 
differences between progeny sired by boars selected using the TN-S vs. TN-E indices.  
Another possibility for the lack of significant differences between sire lines is that the 
TN-E index is not effective at improving resilience and mortality rates of pigs in the face 
of a PRRSV challenge.  Selection for multiple generations using each index may allow us 
to test which of the above explanations for our results is most likely.  However, the TN-S 
pigs (selected for increased feed efficiency) were significantly more efficient throughout 
the entire study.  These pigs also had a numerically lower mortality rate, suggesting the 
importance of feed efficiency rather than feed intake as an indicator for tolerance during a 
virulent disease challenge.   
The scope of this study allowed collection of phenotypic and genetic data on over 
1,400 animals after exposure to PRRSV.  Additionally, further evaluation of genetic 
variation following PRRSV viral infection is possible.  The data collected are a resource 
for future analyses to improve genetic selection of resilience to disease challenge. 
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 Table 3.1: Performance of pigs sired by Topigs Norsvin-Standard 
(TN-S) and -Efficiency (TN-E) boar groups from birth to 
weaning. (SEM) 
 
Sire Group  
  TN-E TN-S P-value 
Pigs, n 727 730   
Birth weight, kg 1.45 (0.36) 1.52 (0.30) 0.06 
Birth - wean ADG 0.22 (0.01) 0.22 (0.01) 0.95 
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 Table 3.2:  Performance of pigs sired by Topigs Norsvin-Standard 
(TN-S) and -Efficiency (TN-E) boar groups from wean to finish. 
(SEM) 
  Sire Group 
  TN-E TN-S P-value 
Pens, n 27 27   
Wean Weight, kg 6.15 (0.13) 6.20 (0.13) 0.65 
Wean Age, days 20.33 (0.3) 20.38 (0.3) 0.86 
Wean to Finish       
Average market weight, kg 124.37 (0.43) 124.72 (0.43) 0.33 
Average daily gain, kg/day 0.76 (0.01) 0.77 (0.01) 0.27 
Average daily feed intake, kg/day 1.87 (0.02) 1.84 (0.02) 0.11 
Feed conversion 2.45 (0.01) 2.39 (0.01) <0.0001 
0 – 42 dpi       
Average daily gain, kg/day 0.56 (0.01) 0.56 (0.01) 0.82 
Average daily feed intake, kg/day 1.22 (0.03) 1.16 (0.03) 0.01 
Feed conversion 2.20 (0.02) 2.08 (0.02) 0.01 
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 Table 3.3: Comparison of percent final outcomes between pigs sired 
by Topigs Norsvin-Standard (TN-S) and -Efficiency (TN-E) boar 
groups. (SEM) 
  Sire Group 
1Final Outcome  TN-E TN-S  P-value 
2Full Value, % 81.8% (0.02) 83.7% (0.02) 0.39  
3Mortality, % 16.2% (0.02) 14.4% (0.02) 0.29  
4Defect culls, % 0.7% (0.01) 0.5% (0.01) 0.73  
5Light culls, % 1.2% (0.01) 1.4% (0.01) 0. 79  
 
 
 
 
 
 
 
 
 
 
                                                          
1 Final Outcome is a binary outcome assigned to every pig at the end of the study.  
2 Full Value (FV) is assigned to pigs harvested at an optimum price to the packer, free of defects and >104 
kg. 
3 Mortality is assigned to pigs that die during the wean to harvest period. 
4 Defect cull is assigned to pigs that were sold to a secondary market due to a genetic defect. 
5 Light cull is assigned to pigs that were sold to a secondary market weighing <104 kg. 
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Table 3.4: Carcass performance differences between pigs sired by Topigs 
Norsvin-Standard (TN-S) and -Efficiency (TN-E) boar lines. (SEM) 
 Sire Group 
Carcass Attribute  TN-E TN-S  P-value 
Hot carcass weight, kg 92.60 (0.36) 92.80 (0.36) 0.68  
Yield, % 74.4% (0.01) 74.2% (0.01) 0.17  
Back fat, mm 17.5 (1.9) 17.1 (1.9) 0.13 
Loin depth, mm 63.2 (4.8) 63.7 (4.8) 0.39  
Lean, % 55.1% (0.2) 55.7% (0.2) 0.02  
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Table 3.5: Pathogens detected pre-challenge and post-challenge. 
Pre-Challenge Post-Challenge 
²Influenza ³Salmonella 
¹Streptococcus suis ² ¹PRRSv 174 
³Rotavirus ¹Actinobacillus suis 
³Salmonella ¹Haemophilus parasuis 
 ¹Pasturella multocida 
 ¹Bronchopneumonia 
 ¹Escherichia coli haemolytic 
 
¹Detected in tissue samples 
²Detected in oral samples  
³Detected in fecal samples 
